Abstract
Type 2 diabetes mellitus (T2D) currently affects almost 10% of the global population, accounting for thousands of amputations and deaths. In T2D, there is a failure in the secretion and signaling of insulin, in addition to an increase in the plasma concentration of glucagon, effects that contribute to the establishment of hyperglycemia. Several strategies have been used in the treatment o…